28 March 2008
Renal transplantation practice in Iran and the middle east: report from Iran and a review of the literature
Behzad Einollahi, Saeed TaheriAnn Transplant 2008; 13(1): 5-14 :: ID: 843635
Abstract
Transplantation is the best treatment of end-stage renal disease (ESRD. Life expectancy, the quality of life and reduced medical expenses are greater with kidney transplantation than with maintenance dialysis. However, organ shortage remains the central problem in kidney transplantation. To tackle this problem, we, in Iran, have initiated a living unrelated donor (LURD) program using emotionally related persons, friends and well-motivated volunteers as organ donors, which resulted in eliminating the waiting list. The Iranian transplant program is the most active in the Middle East region in providing equitable, quick, and intermediary-free access to affordable kidney transplantation for everyone regardless of gender and economic circumstances. The results of transplants from living unrelated donors have been very encouraging. This article deals with the kidney transplantation practice in Iran and other Middle Eastern countries, and describes Iran’s kidney transplantation experience with cadaveric, living related and living unrelated donors. In conclusion, kidney transplantation experience in the Middle East region is an active practice. Most countries have uplifting trends and effectve programs are establishing inside countries. However, the practice should be further promoted and organized towards allograft procurement from deceased donors and in this way passing and enacting proper legislations must be more seriously taken into consideration.
Keywords: renal transplantation, Kidney, Iran model, Middle East, ESRD
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






